Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

From NAFLD to NASH and HCC: Pathogenetic Mechanisms and Therapeutic Insights

Author(s): Samuele De Minicis, Chris Day and Gianluca Svegliati-Baroni

Volume 19, Issue 29, 2013

Page: [5239 - 5249] Pages: 11

DOI: 10.2174/1381612811319290006

Price: $65

Abstract

NAFLD is the most common liver disease worldwide but it is the potential evolution to cirrhosis and hepatocellular carcinoma (HCC) that makes NAFLD of such clinical importance. The current work provides an overview of the main mechanims and potential therapeutical insights involved in NAFLD, NASH, fibrosis and HCC progression.

Keywords: NAFLD, NASH, fibrosis, microbiota, bacterial translocation.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy